TrialJournal for immunotherapy of cancer2018

Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results.

Jacek Mackiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.